MOST NOTEWORTHY: The medical supplies and devices sector, East West Bancorp, Tempur Pedic and AbitibiBowater were today's noteworthy initiations:

• Credit Suisse initiated the medical supplies and devices sector with a Market Weight rating and started shares of Edwards Lifesciences (NYSE: EW) and Becton, Dickinson and Co (NYSE: BDX) with Outperform ratings and Medtronic (NYSE: MDT) and Boston Scientific (NYSE: BSX) with Neutral ratings.
  
• East West Bancorp (NASDAQ: EWBC) was initiated with a Buy rating and $36 target at B. Riley; the firm's target implies a 23.1% potential total return over the next twelve months including the stock's 1.35% dividend yield.
  
• Tempur Pedic (NYSE: TPX) was started with an Outperform rating at William Blair, as they find the current valuation attractive for long-term investor given the company's strong position in the specialty sleep products.
  
• Deutsche Bank resumed coverage of AbitibiBowater (NYSE: ABH) with a Hold rating and $29 target, citing the strength of the Canadian dollar and difficult newsprint fundamentals.

OTHER INITIATIONS:

• Banc of America initiated shares of JA Solar (NASDAQ: JASO) and Trina Solar (NYSE: TSL) with Buy ratings and targets of $73 and $76, and initiated Horizon Lines (NYSE: HRZ) and Solarfun Power (NASDAQ: SOLF) with Neutral ratings and targets of $34 and $14.

Chuck Carlson is the newsletter industry leader in DRIPs, or dividend reinvestment plans. Not surprisingly, then, his newsletter is called The DRIP Investor.

For those unfamiliar with these programs, DRIPs are dividend reinvestment plans, which are set up by companies to make it easier and more cost-effective for individual investors to buy and accumulate long-term positions by reinvesting dividends back into additional shares.

Usually, the commissions and other related costs of DRIPs are low, and in some cases, free. Says Carlson, "All things equal, a DRIP with no fees is better than one that charges fees."

He continues, "To be sure, I'm not suggesting investors should automatically discard a DRIP because it charges fees. Still, fees erode investment returns, so taking fees into account in your selection process makes sense."

To help investors find the most cost-effective way of building portfolios, the advisor has conducted a review of "fee-free" plans. Using a proprietary system that ranks 5,000 stocks based on over 100 metrics, he has developed a "starter portfolio" for those with limited investment funds. Such a starter portfolio, he notes, could be developed with as little as $1,000 to start.

He notes, "If I were constructing a reasonably diversified starter portfolio of six "fee-free" stocks, I would focus on the following issues: